Alopecia Areata: New Therapies

The discussion celebrates International Women's Day and addresses the topic of alopecia areata, highlighting its prevalence and impact particularly among African Americans, and its significance as an autoimmune condition. The speaker expresses concern about recent studies that might underestimate the number of individuals affected by alopecia areata, acknowledging a rise in cases post-COVID-19. The speaker shares patient experiences involving the effects of COVID-19 and vaccines on hair loss in those already receiving treatment with JAK inhibitors. Emphasizing the ongoing nature of life and the unpredictability of the condition's response to therapy, the speaker introduces a lineup of experts who will present insights on diagnostics, treatment options, including JAK inhibitors for adults and children, procedural interventions, and global practices in alopecia treatment. The session aims to foster understanding and provide practical knowledge about managing this condition while paving the way for audience questions and discussions.